Found: 48
Select item for more details and to access through your institution.
Oral aripiprazole in the treatment of tic disorders in China: a cost-effectiveness analysis based on a mapping algorithm derived from a Chinese children and adolescents population.
- Published in:
- Child & Adolescent Psychiatry & Mental Health, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13034-024-00786-0
- By:
- Publication type:
- Article
Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1403805
- By:
- Publication type:
- Article
Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 965, doi. 10.1007/s00228-024-03665-x
- By:
- Publication type:
- Article
External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 4, p. 437, doi. 10.1002/jcph.2392
- By:
- Publication type:
- Article
Randomized controlled trial of an app for cancer pain management.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 4, p. 1, doi. 10.1007/s00520-024-08442-1
- By:
- Publication type:
- Article
Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03285-3
- By:
- Publication type:
- Article
Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03274-6
- By:
- Publication type:
- Article
Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatment.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6708
- By:
- Publication type:
- Article
Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.
- Published in:
- International Journal of Clinical Pharmacy, 2024, v. 46, n. 1, p. 150, doi. 10.1007/s11096-023-01657-y
- By:
- Publication type:
- Article
Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration–Time Curve: Based on Peak and Trough Concentrations in Saliva.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 58, doi. 10.1002/jcph.2345
- By:
- Publication type:
- Article
Population pharmacokinetics of polymyxin B in patients with liver dysfunction.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 12, p. 3561, doi. 10.1111/bcp.15855
- By:
- Publication type:
- Article
Movement disorders associated with antiseizure medications: A real‐world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 11, p. 3389, doi. 10.1111/bcp.15836
- By:
- Publication type:
- Article
Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30578
- By:
- Publication type:
- Article
Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1238, doi. 10.1002/psp4.13004
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 9, p. 1036, doi. 10.1002/jcph.2261
- By:
- Publication type:
- Article
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231171038
- By:
- Publication type:
- Article
Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231168215
- By:
- Publication type:
- Article
Efficacy and safety of rituximab biosimilars or reference product as first‐line treatment in patients with low‐tumour‐burden follicular lymphoma: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 12, p. 1923, doi. 10.1111/jcpt.13799
- By:
- Publication type:
- Article
Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 11, p. 2323, doi. 10.3390/pharmaceutics14112323
- By:
- Publication type:
- Article
Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221130501
- By:
- Publication type:
- Article
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone for advanced esophageal cancer: a cost-effectiveness analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221122733
- By:
- Publication type:
- Article
Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1006860
- By:
- Publication type:
- Article
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 9, p. 1447, doi. 10.1007/s00228-022-03359-2
- By:
- Publication type:
- Article
Rapid, simple, and economical LC–MS/MS method for simultaneous determination of ceftazidime and avibactam in human plasma and its application in therapeutic drug monitoring.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 9, p. 1426, doi. 10.1111/jcpt.13693
- By:
- Publication type:
- Article
Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116604
- By:
- Publication type:
- Article
External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.835037
- By:
- Publication type:
- Article
The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3052, doi. 10.1111/bcp.15276
- By:
- Publication type:
- Article
Cost-effectiveness analysis of axicabtagene ciloleucel vs. salvage chemotherapy for relapsed or refractory adult diffuse large B-cell lymphoma in China.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6113, doi. 10.1007/s00520-022-07041-2
- By:
- Publication type:
- Article
Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 5, p. 609, doi. 10.1002/jcph.1992
- By:
- Publication type:
- Article
Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 1004, doi. 10.3390/pharmaceutics14051004
- By:
- Publication type:
- Article
Systematic review and cost-effectiveness of pharmacokinetically guided sunitinib individualized treatment for patients with metastatic renal cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221085212
- By:
- Publication type:
- Article
Fixed-dose administration and pharmacokinetically guided adjustment of busulfan dose for patients undergoing hematopoietic stem cell transplantation: a meta-analysis and cost-effectiveness analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 3, p. 667, doi. 10.1007/s00277-021-04733-3
- By:
- Publication type:
- Article
Molecular Mechanism of Gelsemium elegans (Gardner and Champ.) Benth. Against Neuropathic Pain Based on Network Pharmacology and Experimental Evidence.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.792932
- By:
- Publication type:
- Article
Gelsemium elegans Benth: Chemical Components, Pharmacological Effects, and Toxicity Mechanisms.
- Published in:
- Molecules, 2021, v. 26, n. 23, p. 7145, doi. 10.3390/molecules26237145
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.732912
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of screening for primary aldosteronism in China.
- Published in:
- Clinical Endocrinology, 2021, v. 95, n. 3, p. 414, doi. 10.1111/cen.14478
- By:
- Publication type:
- Article
Systematic review and cost‐effectiveness of bosentan and sildenafil as therapeutic drugs for pediatric pulmonary arterial hypertension.
- Published in:
- Pediatric Pulmonology, 2021, v. 56, n. 7, p. 2250, doi. 10.1002/ppul.25427
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 4263, doi. 10.2147/CMAR.S293983
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.632818
- By:
- Publication type:
- Article
A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
- Published in:
- BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03273-7
- By:
- Publication type:
- Article
High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.572444
- By:
- Publication type:
- Article
First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.602185
- By:
- Publication type:
- Article
Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4503, doi. 10.2147/CMAR.S248020
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 9483, doi. 10.2147/CMAR.S226243
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 9195, doi. 10.2147/CMAR.S223441
- By:
- Publication type:
- Article
From population to individuals: a new indicator for evaluating the appropriateness of clinical application of antibiotics.
- Published in:
- BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0245-y
- By:
- Publication type:
- Article
Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae.
- Published in:
- Antimicrobial Resistance & Infection Control, 2017, v. 6, p. 1, doi. 10.1186/s13756-017-0235-7
- By:
- Publication type:
- Article
Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 6, p. 365, doi. 10.1007/s40261-015-0290-x
- By:
- Publication type:
- Article